Enter your terms above and click the 'Search' button.

Showing articles 0 to 9 of 9 Filter Applied: polyneuropathy,chronic inflammatory demyelinating (Click to remove) Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases JAMA 291:2367-2375, Dalakas,M.C., 2004 Intravenous Immunoglobulin Treatment of Neurological Disease JNNP 60:359-361, Otten,A.,et al, 1996 Clinical Reasoning: A 49-year-old man with Progressive Numbness, Weakness, and Evidence of Leptomeningeal Enhancement Neurol 90:e90-e93, Lovett, A.,et al, 2018 Evidence-based Guideline: Intravenous Immunoglobulin in the Treatment of Neuromascular Disorders Neurol 78:1009-1015, Patwa,H.S.,et al, 2012 Evidence-Based Guideline Update: Plasmapheresis in Neurologic Disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology Neurol 76:294-300, Cortese,I.,et al, 2011 Intravenous Immunoglobulin Treatment in Neurologic Disorders Arch Neurol 56:1025-1027,1032, Sorensen,P.S., 1999 Intravenous Immunoglobulin in the Treatment of Autoimmune Neuromuscular Diseases:Present Status and Practical Therapeutic Guidelines Muscle & Nerve 22:1479-1497, Dalakas,M.C., 1999 Chronic Demyelinating Polyneuropathy:Improvement after Sepsis Neurol 46:848, 8501996., Ropper,A.H., 1996 Immunologic Aspects of Neurological and Neuromuscular Diseases JAMA 268:2918-2922, Zweiman,B.&Levinson,A.I., 1992 Showing articles 0 to 9 of 9